MCF Advisors’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-11
Closed -$1.98K 1407
2026
Q1
$1.98K Buy
+11
New +$1.88K ﹤0.01% 1199
2025
Q1
Sell
-27
Closed -$2.33K 916
2024
Q4
$2.33K Buy
27
+15
+125% +$1.49K ﹤0.01% 834
2024
Q3
$1.14K Sell
12
-6
-33% -$533 ﹤0.01% 896
2024
Q2
$1.72K Hold
18
﹤0.01% 863
2024
Q1
$2.37K Buy
18
+11
+157% +$1.35K ﹤0.01% 798
2023
Q4
$1.01K Hold
7
﹤0.01% 836
2023
Q3
$1.19K Hold
7
﹤0.01% 815
2023
Q2
$1.56K Hold
7
﹤0.01% 738
2023
Q1
$1.55K Hold
7
﹤0.01% 736
2022
Q4
$1.59K Sell
7
-195
-97% -$52K ﹤0.01% 703
2022
Q3
$53K Hold
202
0.01% 333
2022
Q2
$42K Hold
202
﹤0.01% 339
2022
Q1
$45K Buy
+202
New +$42.7K ﹤0.01% 339
2021
Q4
Sell
-7
Closed -$2K 66
2021
Q3
$2K Buy
+7
New +$1.5K ﹤0.01% 598

Other funds holding ALB

MCF Advisors's ALB Position: Q2 2026 in Review

MCF Advisors sold out of Albemarle (ALB) in Q2 2026, closing a stake of 11 shares — an estimated $1.98K sold.

MCF Advisors first reported a position in ALB in Q3 2021 and held it in 14 quarters. The position peaked at $53K in Q3 2022. 942 funds tracked by Wall St. Rank hold ALB as of Q2 2026.

  • MCF Advisors reported no remaining Albemarle position as of Q2 2026 after selling out during the quarter.
  • MCF Advisors sold 11 Albemarle shares in Q2 2026, an estimated $1.98K.
  • MCF Advisors first reported a position in Albemarle in Q3 2021 and held it in 14 quarters.
  • MCF Advisors's Albemarle position peaked at $53K in Q3 2022.
  • 942 funds tracked by Wall St. Rank held Albemarle as of Q2 2026.

Based on MCF Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.